Product Description: Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]Chittenden T D, et al. IMGN289, an EGFR-targeting antibody-maytansinoid conjugate with potent activity against non-small cell lung cancer (NSCLC) regardless of dependency on EGFR pathway. Cancer Research, 2013, 73(8_Supplement): 5467-5467.
CAS Number: 1622327-38-1
Molecular Weight: N/A
Compound Purity: 95.00
Research Area: Cancer
Solubility: H2O
Target: EGFR